Fiel, Rome B.
HRN: 21-17-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2022
OXACILLIN 500MG (VIAL)
06/02/2022
06/08/2022
IV DRIP
115 Mg
Q6
Bacterial Skin Infection, Pcap D
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes